Share. Connect. Create. Grow. · Socialiya
Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.

Novo Nordisk updated investors on Zeus trial outcome. Investors' pre-earnings positioning may also u...

BUSINESS NEWS July 31, 2026

Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.

Novo Nordisk updated investors on Zeus trial outcome. Investors' pre-earnings positioning may also underlie sliding weight loss drug stocks.

15 views 0 likes 0 comments
Share:
Novo Nordisk updated investors on Zeus trial outcome. Investors' pre-earnings positioning may also underlie sliding weight loss drug stocks.

Author: Investor's Business Daily

Read Original Article

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement